# Study of Peripheral Blood CHI3L1 to Predict Tumor Response to Radiotherapy

> **NCT07071688** · — · NOT_YET_RECRUITING · sponsor: **Nanfang Hospital, Southern Medical University** · enrollment: 338 (estimated)

## Conditions studied

- Tumor
- Radiotherapy
- Biomarker

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07071688
- **Lead sponsor:** Nanfang Hospital, Southern Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-07-20
- **Primary completion:** 2028-06-30
- **Final completion:** 2028-12-31
- **Target enrollment:** 338 (ESTIMATED)
- **Last updated:** 2025-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07071688

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07071688, "Study of Peripheral Blood CHI3L1 to Predict Tumor Response to Radiotherapy". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT07071688. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*